AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures

Lei Chen, Dianna J Magliano, Beverley Balkau, Stephen Colagiuri, Paul Z Zimmet, Andrew M Tonkin, Paul Mitchell, Patrick J Phillips and Jonathan E Shaw
Med J Aust 2010; 192 (4): 197-202.


Objective: To develop and validate a diabetes risk assessment tool for Australia based on demographic, lifestyle and simple anthropometric measures.

Design and setting: 5-year follow-up (2004–2005) of the Australian Diabetes, Obesity and Lifestyle study (AusDiab, 1999–2000).

Participants: 6060 AusDiab participants aged 25 years or older who did not have diagnosed diabetes at baseline.

Main outcome measures: Incident diabetes at follow-up was defined by treatment with insulin or oral hypoglycaemic agents or by fasting plasma glucose level ≥ 7.0 mmol/L or 2-hour plasma glucose level in an oral glucose tolerance test ≥ 11.1 mmol/L. The risk prediction model was developed using logistic regression and converted to a simple score, which was then validated in two independent Australian cohorts (the Blue Mountains Eye Study and the North West Adelaide Health Study) using the area under the receiver operating characteristic curve (AROC) and the Hosmer–Lemeshow (HL) χ2 statistic.

Results: 362 people developed diabetes. Age, sex, ethnicity, parental history of diabetes, history of high blood glucose level, use of antihypertensive medications, smoking, physical inactivity and waist circumference were included in the final prediction model. The AROC of the diabetes risk tool was 0.78 (95% CI, 0.76–0.81) and HL χ2 statistic was 4.1 (P = 0.85). Using a score ≥ 12 (maximum, 35), the sensitivity, specificity and positive predictive value for identifying incident diabetes were 74.0%, 67.7% and 12.7%, respectively. The AROC and HL χ2 statistic in the two independent validation cohorts were 0.66 (95% CI, 0.60–0.71) and 9.2 (P = 0.32), and 0.79 (95% CI, 0.72–0.86) and 29.4 (P < 0.001), respectively.

Conclusions: This diabetes risk assessment tool provides a simple, non-invasive method to identify Australian adults at high risk of type 2 diabetes who might benefit from interventions to prevent or delay its onset.

  • Lei Chen1
  • Dianna J Magliano2
  • Beverley Balkau2,3
  • Stephen Colagiuri4
  • Paul Z Zimmet2
  • Andrew M Tonkin1
  • Paul Mitchell5
  • Patrick J Phillips6
  • Jonathan E Shaw2

  • 1 Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC.
  • 2 Baker IDI Heart and Diabetes Institute, Melbourne, VIC.
  • 3 Centre for Research in Epidemiology and Public Health, Institut National de la Santé et de la Recherche Médicale, University Paris-Sud, Villejuif, France.
  • 4 Institute of Obesity, Nutrition and Exercise, University of Sydney, Sydney, NSW.
  • 5 Centre for Vision Research, Westmead Millennium Institute, University of Sydney, Sydney, NSW.
  • 6 Department of Endocrinology, Queen Elizabeth Hospital, Adelaide, SA.


The AUSDRISK was developed by the Baker IDI Heart and Diabetes Institute on behalf of the Australian, state and territory governments as part of the Council of Australian Governments (COAG) Reducing the Risk of Type 2 Diabetes initiative.

Competing interests:

Funding for the AUSDRISK instrument was provided by the COAG as part of the Reducing the Risk of Type 2 Diabetes initiative. Oversight of this work was provided by a management committee comprising diabetes expertise and jurisdictional representation. Other supportive funding for the AusDiab study is listed in the Acknowledgements.

  • 1. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787.
  • 2. Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829-834.
  • 3. Magliano DJ, Shaw JE, Shortreed SM, et al. Lifetime risk and projected population prevalence of diabetes. Diabetologia 2008; 51: 2179-2186.
  • 4. Hussain A, Claussen B, Ramachandran A, Williams R. Prevention of type 2 diabetes: a review. Diabetes Res Clin Pract 2007; 76: 317-326.
  • 5. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002; 19: 708-723.
  • 6. Simmons RK, Harding AH, Wareham NJ, Griffin SJ. Do simple questions about diet and physical activity help to identify those at risk of type 2 diabetes? Diabet Med 2007; 24: 830-835.
  • 7. Aekplakorn W, Bunnag P, Woodward M, et al. A risk score for predicting incident diabetes in the Thai population. Diabetes Care 2006; 29: 1872-1877.
  • 8. Balkau B, Lange C, Fezeu L, et al. Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2008; 31: 2056-2061.
  • 9. Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003; 26: 725-731.
  • 10. Schulze MB, Hoffmann K, Boeing H, et al. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 2007; 30: 510-515.
  • 11. Australian Government Department of Health and Ageing. The Australian Type 2 Diabetes Risk Assessment Tool. Canberra: DoHA, 2008. BCA25769400199781/$File/austool.pdf (accessed Jan 2010).
  • 12. Dunstan DW, Zimmet PZ, Welborn TA, et al. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) — methods and response rates. Diabetes Res Clin Pract 2002; 57: 119-129.
  • 13. Magliano DJ, Barr EL, Zimmet PZ, et al. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2008; 31: 267-272.
  • 14. Australian Bureau of Statistics. Australian Standard Classification of Occupations (ASCO). 2nd ed. Canberra: ABS, 1997. (ABS Cat. No. 1220.0.) 235A67?Open (accessed Dec 2008).
  • 15. Australian Institute of Health and Welfare. The Active Australia Survey: a guide and manual for implementation, analysis and reporting. Canberra: AIHW, 2003. (AIHW Cat. No. CVD 22.) (accessed Dec 2008).
  • 16. World Health Organization Consultation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva: WHO, 2006.
  • 17. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Brussels: International Diabetes Federation, 2006.
  • 18. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
  • 19. Hosmer DW, Hjort NL. Goodness-of-fit processes for logistic regression: simulation results. Stat Med 2002; 21: 2723-2738.
  • 20. Tobias A, Campbell MJ. Akaike’s information criterion and Schwarz’s criterion. Stata Tech Bull 1998; 45: 23-25.
  • 21. Raftery AE. Bayesian model selection in social research. In: Marsden PV, editor. Sociological methodology. Oxford: Blackwell, 1996: 111-163.
  • 22. Sullivan LM, Massaro JM, D’Agostino RB. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med 2004; 23: 1631-1660.
  • 23. Cugati S, Wang JJ, Rochtchina E, Mitchell P. Ten-year incidence of diabetes in older Australians: the Blue Mountains Eye Study. Med J Aust 2007; 186: 131-135. <MJA full text>
  • 24. Grant JF, Chittleborough CR, Taylor AW, et al. The North West Adelaide Health Study: detailed methods and baseline segmentation of a cohort for selected chronic diseases. Epidemiol Perspect Innov 2006; 3: 4.
  • 25. Schmidt MI, Duncan BB, Bang H, et al. Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2005; 28: 2013-2018.
  • 26. Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 2002; 136: 575-581.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.